Implementing Hepatitis C treatment among HIV/HCV coinfected             INTERIM GUIDANCE FOR CONTINUING HIV PROGRAM SERVICE DELIVERY DURING COVID-19 PANDEMIC             National Integrated Biological and Behavioral Surveillance (IBBS) Survey among PWID            

Implementing Hepatitis C treatment among HIV/HCV coinfected

On Chaitra 8, 2077 (March 21, 2021), NCASC implemented Hepatitis C (HCV) treatment among HIV/HCV coinfected from three ART centers of Kathmandu Valley. The ART centers providing treatment are Sukra Raj Tropical and Infectious Disease Hospital, Bir Hospital and Tribhuwan University Teaching Hospital. NCASC is committed to provide treatment among coinfected and treatment sites will be scaled up in coming fiscal year.